Maxim Group Boosts Nutex Health (NASDAQ:NUTX) Price Target to $50.00

Nutex Health (NASDAQ:NUTX - Free Report) had its price objective lifted by Maxim Group from $45.00 to $50.00 in a research report sent to investors on Tuesday, Marketbeat.com reports. Maxim Group currently has a buy rating on the stock.

Separately, Benchmark boosted their target price on shares of Nutex Health from $30.00 to $45.00 and gave the stock a "buy" rating in a report on Wednesday, August 21st.

Nutex Health Stock Up 23.3 %

Shares of NASDAQ NUTX traded up $6.49 during midday trading on Tuesday, reaching $34.40. The company's stock had a trading volume of 161,007 shares, compared to its average volume of 42,006. The company has a current ratio of 1.59, a quick ratio of 1.55 and a debt-to-equity ratio of 3.04. Nutex Health has a fifty-two week low of $4.16 and a fifty-two week high of $39.90. The stock has a 50 day simple moving average of $22.67 and a 200-day simple moving average of $13.60. The stock has a market capitalization of $174.27 million, a price-to-earnings ratio of -3.32 and a beta of 0.11.

Insiders Place Their Bets

In related news, CFO Jon Christian Bates bought 1,350 shares of the business's stock in a transaction dated Thursday, August 22nd. The stock was bought at an average price of $21.46 per share, for a total transaction of $28,971.00. Following the purchase, the chief financial officer now owns 2,277 shares in the company, valued at $48,864.42. This represents a 100.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 38.52% of the company's stock.

Hedge Funds Weigh In On Nutex Health

A number of hedge funds have recently bought and sold shares of NUTX. Essex Investment Management Co. LLC acquired a new position in shares of Nutex Health during the 3rd quarter worth approximately $1,579,000. International Assets Investment Management LLC acquired a new stake in Nutex Health during the third quarter worth approximately $188,000. Finally, Thompson Davis & CO. Inc. bought a new position in Nutex Health during the 3rd quarter worth $494,000. 5.32% of the stock is owned by institutional investors.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.